Ambee Pharmaceuticals PLC announcements

253 Dhaka Stock Exchange announcements for Ambee Pharmaceuticals PLC (AMBEEPHA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2015 (12).

1. 1 Nov 2015
   Q3

   EPS was Tk. 1.38 for July-September, 2015 as against Tk. 1.92 for July-September, 2014; EPS was Tk. 3.10 for January-September, 2015 as against Tk. 3.51 for January-September, 2014. NOCFPS was Tk. 3.25 for January-September, 2015 as against Tk. 3.13 for January-September, 2014. NAV per share was Tk. 24.51 as of September 30, 2015 and Tk. 24.21 as of December 31, 2014.

2. 26 Oct 2015
   Reschedule of Board Meeting

   The Company has further informed that due to unavoidable circumstances, the meeting of the Board of Directors of the Company will now be held on October 29, 2015 at 3:15 PM instead of October 28, 2015 to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on September 30, 2015.

3. 21 Oct 2015
   Board Meeting schedule under LR 16(1)

   As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2015 at 3:15 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on September 30, 2015.

4. 29 Jul 2015
   Q2 Financials

   EPS for April-June, 2015 was Tk. 0.95 as against Tk. 0.79 for April-June, 2014, EPS for Jan-June, 2015 was Tk. 1.72 as against Tk. 1.59 for Jan-June, 2014. NOCFPS was Tk. 1.30 for Jan-June, 2015 as against Tk. 1.10 for Jan-June, 2014. NAV per share was Tk. 25.93 as of June 30, 2015 and Tk. 24.21 as of December 31, 2014.

5. 25 May 2015
   Resumption News after Record Date

   Normal trading of the shares of the Company will resume on 26.05.2015 after record date.<br>

6. 20 May 2015
   Spot News for AGM

   Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 21.05.2015 to 24.05.2015. Trading of the shares of the Company will remain suspended on record date i.e., 25.05.2015.

7. 13 May 2015
   Q1 Financials

   Profit after tax from Jan15 to March15 was Tk. 1.85 million with EPS of Tk. 0.77 as against Tk. 1.91 million and Tk. 0.80 respectively for the same period of the previous year.

8. 11 May 2015
   Dividend Declaration

   The Board of Directors has recommended 28% cash dividend for the year ended on December 31, 2014. Date of AGM: 14.06.2015, Time: 10:00 AM, Venue: Ambee Pharmaceuticals Limited, 184/1 Tejgaon I/A, Dhaka-1208. Record Date: 25.05.2015. The Company has also reported EPS of Tk. 3.13, NAV per share of Tk. 24.21 and NOCFPS of Tk. 15.50 for the year ended on December 31, 2014.

9. 11 May 2015
   Price Limit Open

   There will be no price limit on the trading of the shares of the Company today (11.05.2015) following its corporate declaration.

10. 10 May 2015
    Board Meeting schedule under LR 30

    As per Regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of the Board of Directors will be held on May 10, 2015 at 3:15 PM to consider, among others, audited financial statements of the Company for the year ended on December 31, 2014.

11. 25 Mar 2015
    Query Response

    In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike.

12. 25 Feb 2015
    Query Response

    In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike.

Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.